HLA class I immune editing in JAK2 V617F and CALR exon 9 mutation driven myeloproliferative malignancies

被引:0
|
作者
Ivanova, Milena [1 ]
Tsvetkova, Gergana [2 ]
Micheva, Iliana [3 ]
Lessichkova, Spaska [1 ]
Petrova, Zasmina [4 ]
Ivanova, Anela [4 ]
Madjarova, Galja [4 ]
Hadjiev, Evgueniy [2 ]
Shivarov, Velizar [5 ]
机构
[1] Med Univ, Univ Hosp Alexandrovska, Dept Clin Immunol, Sofia, Bulgaria
[2] Med Univ, Univ Hosp Alexandrovska, Dept Clin Hematol, Sofia, Bulgaria
[3] Med Univ, Univ Hosp Sveta Marina, Clin Hematol, Varna, Bulgaria
[4] Sofia Univ St Kl Ohridski, Fac Chem & Pharm, Dept Phys Chem, Sofia, Bulgaria
[5] Med Univ Pleven, Dept Expt Res, Pleven, Bulgaria
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P2
引用
收藏
页码:366 / 367
页数:2
相关论文
共 50 条
  • [41] JAK2 V617F mutation in philadelphia chromosome-positive myeloproliferative disease
    Yun, Hyeong-Kee
    Shin, Myung-Geun
    Moon, Chang-Jin
    Kim, Hye-Ran
    Lee, Sun-Young
    Kim, Hyeoung-Joon
    Cho, Duck
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 112 - 112
  • [42] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    Langabeer, S. E.
    Ainle, F. Ni
    Conneally, E.
    Lawler, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (02) : 105 - 109
  • [43] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR
    Waterhouse, M.
    Pfeifer, D.
    Follo, M.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [44] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    S. E. Langabeer
    F. Ni Ainle
    E. Conneally
    M. Lawler
    Irish Journal of Medical Science, 2007, 176 : 105 - 109
  • [45] Concomitant BCR ABL Translocation and JAK2 V617F Mutation in Myeloproliferative Disorders
    Hummel, J. M.
    Sanks, J.
    Chiselite, M.
    Smith, L. B.
    Johnson, K. Elenitoba
    Lim, M. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 869 - 869
  • [46] The JAK2 V617F mutation in patients with anaemia
    S. E. Langabeer
    Irish Journal of Medical Science (1971 -), 2017, 186 : 349 - 350
  • [47] The JAK2 V617F mutation in essential thrombocythemia
    Cho, Young-Uk
    Chung, Hee-Jung
    Chi, Hyun-Sook
    Jang, Seoungsoo
    Park, Chan-Jeoung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 103 - 103
  • [48] The V617F JAK2 mutation inmyelodysplastic/myeloproliferative diseases is associated with marked thrombocytosis
    Billiet, J.
    Nollet, F.
    Van Droogenbroeck, J.
    Hidajat, M.
    Van Hoof, A.
    Criel, A.
    Selleslag, D.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 108 - 108
  • [49] The JAK2 V617F mutation in breast cancer?
    Naeem, Mohammad Abdul
    BREAST JOURNAL, 2020, 26 (03): : 593 - 593
  • [50] THE JAK2 V617F MUTATION IN ISOLATED NEUTROPENIA
    Langabeer, Stephen E.
    EXCLI JOURNAL, 2018, 17 : 1 - 2